# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001601485-26-000026
Filing Date
2026-03-12
Accepted
2026-03-12 16:08:43
Documents
20
Period of Report
2026-03-12
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | angn-20260312.htm iXBRL | 8-K | 25558
2 | EX-99.1 | elicioq425prdraft_31226.htm | EX-99.1 | 18255
6 |  | elicioq425prdraft_31226001.jpg | GRAPHIC | 200181
7 |  | elicioq425prdraft_31226002.jpg | GRAPHIC | 202164
8 |  | elicioq425prdraft_31226003.jpg | GRAPHIC | 176540
9 |  | elicioq425prdraft_31226004.jpg | GRAPHIC | 207455
10 |  | elicioq425prdraft_31226005.jpg | GRAPHIC | 227137
11 |  | elicioq425prdraft_31226006.jpg | GRAPHIC | 269616
12 |  | elicioq425prdraft_31226007.jpg | GRAPHIC | 172432
| Complete submission text file | 0001601485-26-000026.txt |  | 2176101

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | angn-20260312.xsd | EX-101.SCH | 1773
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | angn-20260312_lab.xml | EX-101.LAB | 22516
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | angn-20260312_pre.xml | EX-101.PRE | 13037
23 | EXTRACTED XBRL INSTANCE DOCUMENT | angn-20260312_htm.xml | XML | 3010

Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

EIN.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39990 | Film No.: 26747732
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)